A 28-year-old man from Mumbai presents with a lifelong fear of dogs that has intensified over the past 6 months. He reports that whenever he encounters a dog, he experiences sudden onset palpitations, sweating, trembling, and an overwhelming urge to flee. He avoids parks, streets with dogs, and friends' homes with pets. His anxiety is confined to the presence of dogs; he denies panic attacks in other situations. He acknowledges that his fear is excessive and irrational but feels unable to control it. His occupational and social functioning are significantly impaired. What is the most appropriate first-line treatment?

Explanation

## First-Line Treatment: Cognitive Behavioral Therapy with Graded In Vivo Exposure ### Diagnosis Confirmation: Specific Phobia **Key Point:** This patient meets DSM-5 criteria for Specific Phobia: - **Intense, irrational fear** of a specific object (dogs) - **Immediate anxiety response** upon exposure (palpitations, sweating, trembling) - **Avoidance behavior** that impairs functioning - **Duration ≥6 months** with functional impairment - **Insight intact** — he recognizes the fear is excessive ### Treatment Hierarchy for Specific Phobia ```mermaid flowchart TD A[Specific Phobia Diagnosed]:::outcome --> B{Functional Impairment?}:::decision B -->|Mild| C[Psychoeducation + Self-help]:::action B -->|Moderate to Severe| D[First-line: CBT + Exposure]:::action D --> E[Graded In Vivo Exposure]:::action E --> F[Habituation achieved]:::outcome D --> G{Inadequate Response?}:::decision G -->|Yes| H[Add SSRI or SNRI]:::action G -->|No| I[Maintenance + Relapse Prevention]:::outcome ``` ### Why CBT with Exposure is First-Line | Treatment | Evidence | Mechanism | Role in Specific Phobia | |-----------|----------|-----------|------------------------| | **CBT + Exposure** | Highest efficacy (60–80% remission) | Habituation; extinction learning | **First-line** | | **SSRI/SNRI** | Modest efficacy (30–50%) | Anxiolytic; serotonergic modulation | Adjunct if inadequate CBT response | | **Benzodiazepines** | Short-term relief only | GABA potentiation | **Avoid** — reinforces avoidance, dependence risk | | **Antipsychotics** | No evidence | Dopamine antagonism | Not indicated | **High-Yield:** Exposure therapy works through **extinction learning** — repeated, prolonged exposure to the feared stimulus in a safe context allows the brain to form new, non-threatening associations and reduces conditioned fear responses. ### Graded In Vivo Exposure Protocol **Mnemonic:** STEP-UP - **S**tart with least anxiety-provoking exposure (e.g., picture of a dog) - **T**arget moderate anxiety (e.g., video of dog) - **E**xposure to live dog at distance - **P**rogressive approach and interaction - **U**nderstanding that anxiety peaks then habituates - **P**ractice between sessions (homework) **Clinical Pearl:** Anxiety during exposure follows an inverted-U curve — it rises initially, peaks at 10–20 minutes, then naturally declines as the brain realizes no threat occurs. Premature escape reinforces the phobia; prolonged exposure (30–45 min) is essential. ### Why Each Distractor Fails **Warning:** Benzodiazepines are contraindicated despite providing acute relief because they: - Prevent extinction learning (patient escapes before habituation occurs) - Create psychological and physical dependence - Worsen long-term prognosis [cite:Kaplan & Sadock's Synopsis of Psychiatry 11e Ch 8; DSM-5]